Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

RORA may help regulate hair growth by affecting hair follicle stem cells.

Pexidartinib often causes liver issues and fatigue, especially in women.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Promising cancer treatments were found, but the manufacturer closed.

17β-estradiol can reduce inflammation in the skin.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

MR antagonists may improve skin health and wound healing, especially in aging.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Hyaluronic acid microneedles help deliver minoxidil derivatives effectively for hair regrowth.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

OXTR agonists may promote hair growth and be effective for treating hair loss.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

RTA 408 cream protects mice from radiation skin damage.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.